Increased plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are related to good collateral development in patients with isolated left coronary artery disease

International Journal of Cardiology

Volumn 148, Issue 1, 2011, Pages 117-119

  Orem, Cihan ^a   Kahraman, Nuray ^a   Orem, Asim ^a   Uçar, Utku ^a   Yucesan, Fulya Balaban ^a   Mentese, Ahmet ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Collateral development; Coronary artery disease; Ischemia modified albumin; Lipoprotein associated phospholipase A2

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIA MODIFIED ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; ISOLATED LEFT CORONARY ARTERY DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79952818652     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.01.051     Document Type: Article

References (15)

1. Meier P, Gloekler S, Zbinden R, et al. Beneficial effect of recruitable collaterals. A 10- year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007;116:975-83.
2. Seiler C. The human coronary collateral circulation. Heart 2003;89:1352-7. (Pubitemid 37311106)
3. Gulec S, Ozdemir AO, Maradit-Kremers H, et al. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur J Clin Invest 2006;36:369-75. (Pubitemid 43742693)
4. Reddy KJ, Singh M, Bangit JR, et al. The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review. J Clin Lipid 2009;3:85-93.
5. Demirbag R, Gur M, Yilmaz R, et al. Influence of oxidative stress on the development of collateral circulation in total coronary occlusions. Int J Cardiol 2007;116:14-9. (Pubitemid 46227613)
6. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after coronary artery occlusion by an angioplasty balon in human subjects. J Am Coll Cardiol 1985;5:587-92. (Pubitemid 15141963)
7. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606-7.
8. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidi-form mole. Swiss Med Wkly 2003;133(41-42):563-6. (Pubitemid 37499328)
9. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker formyocardial ischemia - a preliminary report. J Emerg Med 2000;19:311-5.
10. Wilenskya RL, Macpheeb CH. Lipoprotein-associated phospholipase A2 and atherosclerosis. Curr Opin Lipidol 2009;20:415-20.
11. Kerner A, Gruberg L, Goldberg A, et al. Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am J Cardiol 2007;99:509-12. (Pubitemid 46215557)
12. Regieli JJ, Nathoe HM, Koerselman J, et al. Coronary collaterals - insights in molecular determinants and prognostic relevance. Int J Cardiol 2007;116:139-43. (Pubitemid 46241476)
13. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4. (Pubitemid 27193480)
14. Schirmer SH, van Nooijen FC, Piek JJ, et al. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart 2009;95:191-7.
15. Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.